Entry |
|
Name |
Cyamemazine (INN); Tercian (TN) |
Formula |
C19H21N3S
|
Exact mass |
323.1456
|
Mol weight |
323.46
|
Structure |

|
Simcomp |
|
Class |
Neuropsychiatric agent
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
|
Remark |
|
Efficacy |
Antipsychotic, Neuroleptic |
Comment |
Phenothiazine derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AA Phenothiazines with aliphatic side-chain
N05AA06 Cyamemazine
D07307 Cyamemazine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
DG00872 Cyamemazine
D07307 Cyamemazine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR2A
D07307 Cyamemazine (INN)
HTR2C
D07307 Cyamemazine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
DG00872 Cyamemazine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 23
1 C8x C 19.3159 -20.0346
2 C8x C 19.3159 -21.4408
3 C8x C 20.5337 -22.1440
4 C8y C 21.7516 -21.4408
5 C8y C 21.7516 -20.0346
6 C8x C 20.5337 -19.3315
7 S2x S 22.9694 -22.1440
8 C8y C 24.1872 -21.4408
9 C8y C 24.1872 -20.0346
10 N4y N 22.9694 -19.3315
11 C8x C 25.4051 -22.1440
12 C8x C 26.6229 -21.4408
13 C8y C 26.6229 -20.0346
14 C8x C 25.4051 -19.3315
15 C3b C 27.8448 -19.3292
16 N3a N 28.9774 -18.6878
17 C1b C 22.9694 -17.9252
18 C1c C 24.1893 -17.2209
19 C1a C 25.3911 -17.9150
20 C1b C 24.1893 -15.8161
21 N1c N 25.3907 -15.1223
22 C1a C 26.5834 -15.8110
23 C1a C 25.3908 -13.7068
BOND 25
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 8 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 9 14 2
17 13 15 1
18 15 16 3
19 10 17 1
20 17 18 1
21 18 19 1
22 18 20 1
23 20 21 1
24 21 22 1
25 21 23 1
|